Invion Gets License for Accolate

Friday, November 1st, 2013

Invion Limited recently entered into a global license agreement with Accolade Pharma LLC, allowing it to develop and sell inhaled formulations of the latter’s Accolate (zafirlukast). Accolate is indicated for treating a number of respiratory conditions, including asthma. The agreement gives Invion Limited, a clinical-stage drug developer, exclusive and worldwide rights to develop and sell […]